CanniMed acknowledges Aurora offer
Shareholders advised to take no action at this time.
Details regarding acquisition transaction to be forthcoming.
SASKATOON, Saskatchewan -- CanniMed Therapeutics Inc. (“CanniMed”) (TSX: CMED) acknowledges the press release of Aurora Cannabis Inc. (“Aurora”) with respect to the announcement of its intention to make an unsolicited offer (the “Unsolicited Offer”)for all of the common shares of CanniMed on the basis of a certain number of Aurora common shares for each common share of CanniMed based on an exchange ratio (the “Exchange Ratio”) noted in the Aurora press release.
We advise shareholders to take NO action until such time as the Board has had the opportunity to fully consider and make a recommendation regarding the Unsolicited Offer.
At this time, the Board has not received a formal written offer from Aurora. CanniMed notes that the Unsolicited Offer is speculative as the Aurora press release cautions that Aurora may determine not to proceed with its proposal in the circumstances described in the Aurora press release.
- Published: 15 November 2017
- Written by Editor